N-acetylcysteine amide [38520-57-9]

Cat# NB-64-29934-500mg

Size : 500mg

Brand : Neo Biotech

Contact local distributor :


Phone : +1 850 650 7790

N-acetylcysteine amide

Catalog No. T5518 Copy Product Info
Purity: 99.98%
N-Acetylcysteine amide is a thiol antioxidant and a neuroprotective agent with cell permeability and blood-brain barrier permeability. N-Acetylcysteine amide reduces ROS production.

N-acetylcysteine amide

Copy Product Info

N-Acetylcysteine amide is a thiol antioxidant and a neuroprotective agent with cell permeability and blood-brain barrier permeability. N-Acetylcysteine amide reduces ROS production.

N-acetylcysteine amide
Cas No. 38520-57-9
TargetMol | Customer service
Customer service consultation
Select Batch
Purity:99.98%
Appearance:Solid
Color:White
Contact us for more batch information

Product Introduction

Bioactivity
Description
N-Acetylcysteine amide is a thiol antioxidant and a neuroprotective agent with cell permeability and blood-brain barrier permeability. N-Acetylcysteine amide reduces ROS production.
In vitro
METHODS: Human esophageal cancer cells KYSE30 and KYSE150 were treated with LAT1-IN-1 (1-100 mM) for 3 days, and cell viability was measured by MTT assay.
RESULTS: LAT1-IN-1 treatment inhibited cell proliferation in a dose-dependent manner. [1]
METHODS: HTR8 SVneo, JEG-3 and JAR cells were treated with LAT1-IN-1 (0.1-4 µM) for 24 h, and the expression levels of target proteins were detected by Western Blot.
RESULTS: LAT1 protein was significantly reduced after 24 h LAT1-IN-1 treatment, and LAT1-IN-1 could directly regulate the expression of LAT1. [2]
In vivo
METHODS: To assay antitumor activity in vivo, LAT1-IN-1 (200 mg/kg) was administered intravenously to BALB/c nude mice bearing KYSE150 tumors once daily for 14 days.
RESULTS: Daily treatment with LAT1-IN-1 for 14 consecutive days significantly delayed tumor growth. [1]
Cell Research
To determine effectiveness of NACA and NAC in protection of H9c2 cells from DOX-induced toxicity, cells were treated with NACA or NAC at 0.75 mM for 2 h followed by exposure to freshly prepared cell culture medium with DOX in presence or absence of NACA or NAC at designated concentrations. The concentrations of DOX were 0.25 μM, 0.75 μM, 2 μM, 5 μM, 20 μM, and 100 μM. The exposure durations were 24 h, 48 h, or 48 h. Cells incubated with NACA or NAC alone were used as the control[1].
Animal Research
rats were randomly divided into three groups (n=6-8 animals/group): N-acetylcysteine amide?loaded pump (18.5?mg/kg/hr) and a single 150 mg/kg bolus intraperitoneal (IP) injection of NACA given (30 min post-injury) ?N-acetylcysteine amide?(18.5 mg/kg/hr) loaded pump and a single 150 mg/kg bolus injection of N-acetylcysteine amide?given IP (30 min post-injury) ?Vehicle loaded pump and?single vehicle bolus injection given IP (30 min post-injury).?Following random distribution of all animals into one of the three previous groups, experimenters were blinded to treatment group.?The osmotic mini pumps were assembled and implanted immediately after injury and remained in the animals for 7 days[2]
Chemical Properties
Molecular Weight162.21
FormulaC5H10N2O2S
Cas No.38520-57-9
SmilesCC(=O)N[C@@H](CS)C(N)=O
Relative Density.1.226 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 100 mg/mL (616.48 mM), Sonication is recommended.
DMSO: 245 mg/mL (1510.39 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (30.82 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM6.1648 mL30.8242 mL61.6485 mL308.2424 mL
5 mM1.2330 mL6.1648 mL12.3297 mL61.6485 mL
10 mM0.6165 mL3.0824 mL6.1648 mL30.8242 mL
20 mM0.3082 mL1.5412 mL3.0824 mL15.4121 mL
50 mM0.1233 mL0.6165 mL1.2330 mL6.1648 mL
100 mM0.0616 mL0.3082 mL0.6165 mL3.0824 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Citations